Comparison of NIV-NAVA vs. N-CPAP After Extubation in Preterm Infants Study
NCT ID: NCT02590757
Last Updated: 2021-12-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
78 participants
INTERVENTIONAL
2015-12-10
2021-01-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NIV-NAVA
Noninvasive ventilation in this group is practiced with NIV-NAVA
NIV-NAVA
Non-invasive neurally adjusted ventilatory assist
N-CPAP
Patients in this group will receive nasal continuous positive airway pressure as routinely in neonatal intensive care unit.
N-CPAP
Nasal-continuous positive airway pressure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NIV-NAVA
Non-invasive neurally adjusted ventilatory assist
N-CPAP
Nasal-continuous positive airway pressure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* infants who fulfill the the criteria for extubation for 6 hours extubation criteria: Ventilator rate ≤ 25 breaths/min, Peak inspiratory pressure (PIP) ≤ 16cmH2O, Fractional inspired oxygen (FiO2) ≤ 0.3
Exclusion Criteria
* major anomalies which will decrease life expectancy
* any anomalous conditions which involve upper and lower airway
* neuromuscular disease
2 Days
6 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Han-Suk Kim
Professor, Director of Neonatal Intensive Care Unit
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Han-Suk Kim, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Seoul National University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Children's Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Shin SH, Shin SH, Kim SH, Song IG, Jung YH, Kim EK, Kim HS. Noninvasive Neurally Adjusted Ventilation in Postextubation Stabilization of Preterm Infants: A Randomized Controlled Study. J Pediatr. 2022 Aug;247:53-59.e1. doi: 10.1016/j.jpeds.2022.04.025. Epub 2022 Apr 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015-1917
Identifier Type: -
Identifier Source: org_study_id